EULAV Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

EULAV Asset Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.09M	Sell	38,000 -67,000	-64%	-$3.68M	0.05%	155
2025 Q1	$7.42M	Sell	105,000 -3,000	-3%	-$212K	0.18%	116
2024 Q4	$7.1M	Sell	108,000 -23,000	-18%	-$1.51M	0.17%	122
2024 Q3	$9.21M	Buy	131,000 +15,000	+13%	+$1.05M	0.22%	106
2024 Q2	$9.55M	Sell	116,000 -5,800	-5%	-$478K	0.26%	96
2024 Q1	$10.6M	Sell	121,800 -8,200	-6%	-$716K	0.29%	91
2023 Q4	$12.5M	Sell	130,000 -2,036	-2%	-$196K	0.39%	72
2023 Q3	$11.7M	Buy	132,036 +37,000	+39%	+$3.27M	0.43%	69
2023 Q2	$8.24M	Buy	95,036 +10,002	+12%	+$867K	0.31%	82
2023 Q1	$8.27M	Buy	85,034 +2,034	+2%	+$198K	0.33%	84
2022 Q4	$8.59M	Buy	+83,000	New	+$8.59M	0.37%	79
2020 Q4	–	Sell	-134,000	Closed	-$10.2M	–	243
2020 Q3	$10.2M	Sell	134,000 -24,000	-15%	-$1.83M	0.3%	101
2020 Q2	$19.5M	Sell	158,000 -13,000	-8%	-$1.6M	0.64%	53
2020 Q1	$14.5M	Sell	171,000 -26,000	-13%	-$2.2M	0.58%	61
2019 Q4	$16.7M	Sell	197,000 -3,000	-2%	-$254K	0.57%	63
2019 Q3	$13.5M	Sell	200,000 -5,000	-2%	-$337K	0.5%	66
2019 Q2	$17.6M	Buy	205,000 +112,000	+120%	+$9.59M	0.66%	53
2019 Q1	$8.32M	Sell	93,000 -7,000	-7%	-$626K	0.34%	86
2018 Q4	$8.52M	Sell	100,000 -9,000	-8%	-$766K	0.43%	80
2018 Q3	$10.6M	Sell	109,000 -16,000	-13%	-$1.55M	0.45%	75
2018 Q2	$11.8M	Buy	125,000 +26,000	+26%	+$2.45M	0.54%	57
2018 Q1	$8.03M	Sell	99,000 -4,000	-4%	-$324K	0.38%	85
2017 Q4	$9.19M	Sell	103,000 -2,000	-2%	-$178K	0.43%	79
2017 Q3	$9.77M	Buy	105,000 +7,000	+7%	+$651K	0.46%	73
2017 Q2	$8.9M	Buy	98,000 +8,000	+9%	+$727K	0.44%	72
2017 Q1	$7.9M	Sell	90,000 -1,000	-1%	-$87.8K	0.4%	80
2016 Q4	$7.54M	Sell	91,000 -1,000	-1%	-$82.8K	0.41%	82
2016 Q3	$8.51M	Buy	92,000 +21,000	+30%	+$1.94M	0.45%	80
2016 Q2	$5.52M	Hold	71,000	–	–	0.3%	121
2016 Q1	$5.86M	Buy	71,000 +25,000	+54%	+$2.06M	0.33%	115
2015 Q4	$4.82M	Sell	46,000 -15,000	-25%	-$1.57M	0.26%	133
2015 Q3	$6.43M	Buy	61,000 +42,000	+221%	+$4.42M	0.37%	100
2015 Q2	$2.6M	Buy	+19,000	New	+$2.6M	0.14%	216